[1] Huang YF, Bodnar D, Chen CY, et al. Rare genetic variants impact muscle strength. Nat Commun 2023; 14, 3449.
[2] Lan YB, Ke YL, Sun DJY, et al. Associations of muscle-related metrics with respiratory disease in Chinese adults: a prospective cohort study. J Cachexia Sarcopenia Muscle 2025; 16, e13650.
[3] Celis-Morales CA, Welsh P, Lyall DM, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ 2018; 361, k1651.
[4] Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet 2015; 386, 266-73.
[5] Andersen LL, López-Bueno R, Núñez-Cortés R, et al. Association of muscle strength with all-cause mortality in the oldest old: prospective cohort study from 28 countries. J Cachexia Sarcopenia Muscle 2024; 15, 2756-64.
[6] Lawman HG, Troiano RP, Perna FM, et al. Associations of relative handgrip strength and cardiovascular disease biomarkers in U. S. adults, 2011-2012. Am J Prev Med 2016; 50, 677-83.
[7] Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020; 21, 300-7. e2.
[8] Cooper R, Kuh D, Hardy R, et al. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 2010; 341, c4467.
[9] GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388, 1459-544.
[10] Qiu SH, Cai X, Liang Y, et al. Cumulative muscle strength and risk of diabetes: a prospective cohort study with mediation analysis. Diabetes Res Clin Pract 2023; 197, 110562.
[11] Li JJ, Wittert GA, Vincent A, et al. Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metabolism 2016; 65, 883-92.
[12] Qiu SH, Cai X, Yuan Y, et al. Muscle strength and prediabetes progression and regression in middle-aged and older adults: a prospective cohort study. J Cachexia Sarcopenia Muscle 2022; 13, 909-18.
[13] Zhao YH, Hu YS, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol 2014; 43, 61-8.
[14] Gao K, Cao LF, Ma WZ, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. EClinicalMedicine 2022; 44, 101264.
[15] Hu YS, Peng WJ, Ren RJ, et al. Sarcopenia and mild cognitive impairment among elderly adults: the first longitudinal evidence from CHARLS. J Cachexia Sarcopenia Muscle 2022; 13, 2944-52.
[16] von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61, 344-9.
[17] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 Suppl 1, S62-9.
[18] Unger T, Borghi C, Charchar F, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension 2020; 75, 1334-57.
[19] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285, 2486-97.
[20] Peterson MD, Zhang P, Choksi P, et al. Muscle weakness thresholds for prediction of diabetes in adults. Sports Med 2016; 46, 619-28.
[21] Li HB, Zheng DQ, Li ZW, et al. Association of depressive symptoms with incident cardiovascular diseases in middle-aged and older Chinese adults. JAMA Netw Open 2019; 2, e1916591.
[22] Qiu SH, Wang QQ, Chen WJ, et al. Cumulative muscle strength and risk of cardiovascular disease and all-cause mortality: a prospective cohort study. Arch Med Res 2023; 54, 261-9.
[23] Wang K, Fang Y, Zheng RZ, et al. Associations of socioeconomic status and healthy lifestyle with incident dementia and cognitive decline: two prospective cohort studies. EClinicalMedicine 2024; 76, 102831.
[24] Harrell Jr FE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. 2nd ed. Cham: Springer; 2015, 27.
[25] Jang SK, Kim JH, Lee Y. Effect of relative handgrip strength on cardiovascular disease among Korean adults aged 45 years and older: results from the Korean Longitudinal Study of Aging (2006-2016). Arch Gerontol Geriatr 2020; 86, 103937.
[26] Wu YL, Wang WJ, Liu TW, et al. Association of grip strength with risk of all-cause mortality, cardiovascular diseases, and cancer in community-dwelling populations: a meta-analysis of prospective cohort studies. J Am Med Dir Assoc 2017; 18, 551. e17-35.
[27] Wang JX, Yang Y, Su Q, et al. Association between muscle strength and cardiometabolic multimorbidity risk among middle-aged and older Chinese adults: a nationwide longitudinal cohort study. BMC Public Health 2024; 24, 2012.
[28] Dal Canto E, Ceriello A, Rydén L, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol 2019; 26, 25-32.
[29] The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375, 2215-22.
[30] Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019; 48, 16−31. doi:  10.1093/ageing/afy169
[31] Zhu M, Zhu Q, Liu HX, et al. Physical performance outweighs grip strength in predicting diabetes risk: evidence from a prospective cohort study. J Transl Med, 2026; 24, 200. doi:  10.1186/s12967-025-07473-4
[32] Garber CE, Blissmer B, Deschenes MR, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc, 2011; 43, 1334−59. doi:  10.1249/MSS.0b013e318213fefb
[33] Sahin UK, Kirdi N, Bozoglu E, et al. Effect of low-intensity versus high-intensity resistance training on the functioning of the institutionalized frail elderly. Int J Rehabil Res, 2018; 41, 211−7. doi:  10.1097/MRR.0000000000000285
[34] Bao WX, Sun Y, Zhang TF, et al. Exercise programs for muscle mass, muscle strength and physical performance in older adults with sarcopenia: a systematic review and meta-analysis. Aging Dis, 2020; 11, 863−73. doi:  10.14336/AD.2019.1012
[35] Jung CH, Son JW, Kang S, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J, 2021; 45, 1−10. doi:  10.4093/dmj.2019.0067
[36] Qiu SH, Cai X, Yang BQ, et al. Association between cardiorespiratory fitness and risk of type 2 diabetes: a meta-analysis. Obesity (Silver Spring), 2019; 27, 315−24. doi:  10.1002/oby.22368
[37] Tarp J, Støle AP, Blond K, et al. Cardiorespiratory fitness, muscular strength and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetologia, 2019; 62, 1129−42. doi:  10.1007/s00125-019-4867-4